TP53 rs121912611: Understanding Hypomorphic Germline Variants
The rs121912611 variant is a rare germline mutation located within the TP53 gene. It is categorized as a hypomorphic variant, meaning it is associated with a spectrum of cancer predisposition and incomplete penetrance.
What each genotype means
Typical TP53 function
This genotype represents the common, wild-type sequence for this position in the TP53 gene. Individuals with this profile do not carry the specific hypomorphic variant associated with altered cancer predisposition at this site.
This is the most common genotype found in the vast majority of the global population.
Hypomorphic TP53 variant carrier
This genotype indicates the presence of one copy of the hypomorphic TP53 variant. Research suggests this variant may result in reduced tumor suppressor activity, which is associated with a spectrum of cancer predisposition and incomplete penetrance. Please discuss these findings with a genetic counselor or clinician to understand your personal and family health context.
This genotype is very rare in the general population across all major ancestral groups.
Homozygous TP53 variant carrier
This genotype indicates that both copies of the TP53 gene carry this specific variant. Because this variant is a hypomorphic mutation, carrying two copies may significantly impact the function of the p53 protein, which is critical for regulating cell division and preventing tumor growth. It is essential to consult with a medical geneticist or oncologist to discuss the clinical implications of this result.
This genotype is extremely rare and is not typically observed in large-scale population databases.
What is the rs121912611 Variant?
The rs121912611 variant is a specific change in the DNA sequence of the TP53 gene. In genetics, a variant is a permanent change in the DNA sequence that makes up a gene. This particular variant is classified as a germline mutation, meaning it is inherited from a parent and is present in the DNA of virtually every cell in the body. Because it is described as hypomorphic, the protein produced by this version of the gene retains some, but not all, of its normal biological function. This partial loss of function is a key factor in how the variant influences health outcomes, as it differs from complete loss-of-function mutations that are typically associated with more severe, high-penetrance clinical syndromes.
The Role of the TP53 Gene
The TP53 gene provides instructions for making a protein called p53. This protein acts as a tumor suppressor, which means it helps regulate cell division by keeping cells from growing and dividing too rapidly or in an uncontrolled way. Often referred to as the 'guardian of the genome,' p53 plays a critical role in DNA repair and can trigger programmed cell death (apoptosis) if a cell's DNA is damaged beyond repair. When the TP53 gene is mutated, the resulting p53 protein may be unable to effectively monitor the cell cycle or repair DNA damage. This dysfunction can lead to the accumulation of genetic errors, which is a fundamental step in the development of various types of cancer.
Research and Clinical Associations
Research into TP53 variants is complex because the gene is involved in many different biological pathways. While certain high-penetrance TP53 mutations are well-known for causing Li-Fraumeni syndrome—a condition characterized by a very high risk of early-onset cancers—rs121912611 is associated with a more nuanced clinical picture. Studies suggest that this variant exhibits incomplete penetrance, meaning that not everyone who carries the mutation will develop the associated health conditions. The evidence for this variant is considered moderate, as researchers continue to investigate how its hypomorphic nature interacts with other genetic and environmental factors. Because of this variability, clinical interpretation of this variant remains an active area of study, and it is often analyzed in the context of broader cancer predisposition screening.
Population Frequency
The rs121912611 variant is classified as very rare in the general population. Because it is not a common polymorphism, it is not typically found in large-scale population studies at high frequencies. Its rarity makes it difficult for researchers to establish definitive, population-wide risk statistics. Most information regarding this variant comes from clinical case studies or specialized research cohorts rather than general population surveys. As genetic testing becomes more widespread, our understanding of its distribution across different ancestral groups may improve, but currently, it remains an uncommon finding in clinical genetic testing.
Managing Genetic Information
If you have received information about this variant through genetic testing, it is important to understand that this is not a medical diagnosis. Genetic variants are only one piece of a much larger puzzle that includes family history, lifestyle, and other genetic factors. You cannot 'fix' or 'change' a germline variant, but you can use this information to have informed conversations with your healthcare provider. If you are concerned about cancer risk, consult with a genetic counselor or a physician who specializes in oncology or medical genetics. They can help interpret what this result means for your specific health profile and discuss appropriate surveillance or screening strategies. Never make changes to your health management or medical care based on genetic data without professional clinical guidance.
How common is this variant?
The rs121912611 variant is very rare across all major population groups, with no significant common frequency reported in large-scale genomic databases.
Frequently asked questions
Is rs121912611 a diagnosis of cancer?
No, identifying a genetic variant is not a diagnosis of cancer. It simply indicates that you carry a specific change in your DNA that may influence your risk profile, which should be discussed with a medical professional.
What does 'incomplete penetrance' mean?
Incomplete penetrance means that even if a person carries a specific genetic variant, they may not necessarily develop the associated condition. Many factors, including other genes and environmental influences, determine whether the trait is expressed.
Should I be worried if I have this variant?
Genetic results can be concerning, but they are best understood in the context of your personal and family health history. You should share your report with a genetic counselor or doctor to understand the clinical relevance for your specific situation.
Where can I find more information on TP53?
You can find reliable information on the TP53 gene through resources like MedlinePlus Genetics or the National Cancer Institute's TP53 database. These sites provide detailed, science-based explanations of gene function and associated health risks.
Sources & further reading
Educational information only, last refreshed 10/6/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121912611?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TP53
The p.R156H variant is a hypomorphic TP53 mutation identified in families that do not meet traditional Li-Fraumeni syndrome clinical criteria.
This variant is a well-established polymorphism in the TP53 gene often studied for its potential role in cancer susceptibility and cellular response to stress.
A recognized Li-Fraumeni syndrome pathogenic missense variant (p.Arg248Gln) altering sequence-specific DNA binding and predisposing to various early-onset tumors.
Functional codon 72 polymorphism (Arg72Pro) affecting apoptotic capability and associated with differential susceptibility to multiple cancer types.
This variant is a hypomorphic allele associated with incomplete penetrance and late-onset cancer predisposition.
Functional 3' UTR polyadenylation signal polymorphism altering TP53 transcription termination, showing population-specific baseline carrier frequencies across global groups.